AXGN Relative Valuation
AXGN's fair value is calculated using relative valuation, based on historical P/E and P/S ranges and their premiums/discounts relative to a competitor average, adjusted by weights. If the market price exceeds this fair value range, AXGN is overvalued; if below, it's undervalued.
Historical Valuation
AxoGen Inc (AXGN) is now in the Overvalued zone, suggesting that its current forward PS ratio of 5.78 is considered Overvalued compared with the five-year average of -6.72. The fair price of AxoGen Inc (AXGN) is between 13.65 to 26.55 according to relative valuation methord. Compared to the current price of 33.37 USD , AxoGen Inc is Overvalued By 25.71%.
Relative Value
Fair Zone
13.65-26.55
Current Price：33.37
25.71%
Overvalued
620.00
PE
1Y
3Y
5Y
43.75
EV/EBITDA
AxoGen Inc. (AXGN) has a current EV/EBITDA of 43.75. The 5-year average EV/EBITDA is 23.20. The thresholds are as follows: Strongly Undervalued below -186.83, Undervalued between -186.83 and -81.81, Fairly Valued between 128.22 and -81.81, Overvalued between 128.22 and 233.24, and Strongly Overvalued above 233.24. The current Forward EV/EBITDA of 43.75 falls within the Historic Trend Line -Fairly Valued range.
173.48
EV/EBIT
AxoGen Inc. (AXGN) has a current EV/EBIT of 173.48. The 5-year average EV/EBIT is 52.98. The thresholds are as follows: Strongly Undervalued below -1653.85, Undervalued between -1653.85 and -800.44, Fairly Valued between 906.40 and -800.44, Overvalued between 906.40 and 1759.81, and Strongly Overvalued above 1759.81. The current Forward EV/EBIT of 173.48 falls within the Historic Trend Line -Fairly Valued range.
5.78
PS
AxoGen Inc. (AXGN) has a current PS of 5.78. The 5-year average PS is 3.16. The thresholds are as follows: Strongly Undervalued below 0.37, Undervalued between 0.37 and 1.77, Fairly Valued between 4.56 and 1.77, Overvalued between 4.56 and 5.95, and Strongly Overvalued above 5.95. The current Forward PS of 5.78 falls within the Overvalued range.
65.85
P/OCF
AxoGen Inc. (AXGN) has a current P/OCF of 65.85. The 5-year average P/OCF is 127.19. The thresholds are as follows: Strongly Undervalued below -4031.41, Undervalued between -4031.41 and -1952.11, Fairly Valued between 2206.49 and -1952.11, Overvalued between 2206.49 and 4285.79, and Strongly Overvalued above 4285.79. The current Forward P/OCF of 65.85 falls within the Historic Trend Line -Fairly Valued range.
86.65
P/FCF
AxoGen Inc. (AXGN) has a current P/FCF of 86.65. The 5-year average P/FCF is -1.47. The thresholds are as follows: Strongly Undervalued below -270.46, Undervalued between -270.46 and -135.97, Fairly Valued between 133.03 and -135.97, Overvalued between 133.03 and 267.53, and Strongly Overvalued above 267.53. The current Forward P/FCF of 86.65 falls within the Historic Trend Line -Fairly Valued range.
AxoGen Inc (AXGN) has a current Price-to-Book (P/B) ratio of 11.83. Compared to its 3-year average P/B ratio of 5.08 , the current P/B ratio is approximately 132.75% higher. Relative to its 5-year average P/B ratio of 5.02, the current P/B ratio is about 135.93% higher. AxoGen Inc (AXGN) has a Forward Free Cash Flow (FCF) yield of approximately 0.23%. Compared to its 3-year average FCF yield of -4.42%, the current FCF yield is approximately -105.28% lower. Relative to its 5-year average FCF yield of -5.74% , the current FCF yield is about -104.07% lower.
11.83
P/B
Median3y
5.08
Median5y
5.02
0.23
FCF Yield
Median3y
-4.42
Median5y
-5.74
Competitors Valuation Multiple
The average P/S ratio for AXGN's competitors is 4.14, providing a benchmark for relative valuation. AxoGen Inc Corp (AXGN) exhibits a P/S ratio of 5.78, which is 39.67% above the industry average. Given its robust revenue growth of 23.51%, this premium appears sustainable.
Performance Decomposition
1Y
3Y
5Y
Market capitalization of AXGN increased by 80.94% over the past 1 year. The primary factor behind the change was an decrease in P/E Change from -219.54 to -632.99.
The secondary factor is the Revenue Growth, contributed 23.51%to the performance.
Overall, the performance of AXGN in the past 1 year is driven by P/E Change. Which is more unsustainable.
People Also Watch
Frequently Asked Questions
Is AxoGen Inc (AXGN) currently overvalued or undervalued?
AxoGen Inc (AXGN) is now in the Overvalued zone, suggesting that its current forward PS ratio of 5.78 is considered Overvalued compared with the five-year average of -6.72. The fair price of AxoGen Inc (AXGN) is between 13.65 to 26.55 according to relative valuation methord. Compared to the current price of 33.37 USD , AxoGen Inc is Overvalued By 25.71% .
What is AxoGen Inc (AXGN) fair value?
AXGN's fair value is calculated using relative valuation, based on historical P/E and P/S ranges and their premiums/discounts relative to a competitor average , adjusted by weights. The fair price of AxoGen Inc (AXGN) is between 13.65 to 26.55 according to relative valuation methord.
How does AXGN's valuation metrics compare to the industry average?
The average P/S ratio for AXGN's competitors is 4.14, providing a benchmark for relative valuation. AxoGen Inc Corp (AXGN) exhibits a P/S ratio of 5.78, which is 39.67% above the industry average. Given its robust revenue growth of 23.51%, this premium appears sustainable.
What is the current P/B ratio for AxoGen Inc (AXGN) as of Jan 09 2026?
As of Jan 09 2026, AxoGen Inc (AXGN) has a P/B ratio of 11.83. This indicates that the market values AXGN at 11.83 times its book value.
What is the current FCF Yield for AxoGen Inc (AXGN) as of Jan 09 2026?
As of Jan 09 2026, AxoGen Inc (AXGN) has a FCF Yield of 0.23%. This means that for every dollar of AxoGen Inc’s market capitalization, the company generates 0.23 cents in free cash flow.
What is the current Forward P/E ratio for AxoGen Inc (AXGN) as of Jan 09 2026?
As of Jan 09 2026, AxoGen Inc (AXGN) has a Forward P/E ratio of 620.00. This means the market is willing to pay $620.00 for every dollar of AxoGen Inc’s expected earnings over the next 12 months.
What is the current Forward P/S ratio for AxoGen Inc (AXGN) as of Jan 09 2026?
As of Jan 09 2026, AxoGen Inc (AXGN) has a Forward P/S ratio of 5.78. This means the market is valuing AXGN at $5.78 for every dollar of expected revenue over the next 12 months.